Palpitations and Breathlessness During Pregnancy

At 32 weeks, a pregnant patient reports episodes of racing heartbeat, progressive exertional breathlessness, orthopnea, and a clear loss of exercise tolerance. The pulse is irregular, hemoglobin is low, and one calf is more swollen than the other. Common pregnancy changes may contribute, but they cannot account safely for all findings without rhythm, thromboembolism, and cardiac evaluation.

Case focus#

Stabilize any maternal hemodynamic or respiratory compromise according to its cause, capture the rhythm, and evaluate anemia, thyroid disease, pulmonary embolism, and cardiomyopathy using pregnancy-appropriate pathways. Maternal diagnosis and treatment protect fetal health; avoiding indicated imaging or therapy is not a neutral fetal-safety choice.

This analysis concentrates on calibration. It compares plausible explanations, asks which observations genuinely discriminate among them, and keeps the working diagnosis open to revision as new evidence arrives.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this cardiopulmonary symptoms in pregnancy analysis, the working frame must remain broad enough to compare Physiologic pregnancy adaptation, Clinically important arrhythmia, Iron deficiency anemia, Pulmonary thromboembolism without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: An obstetric triage unit with ECG, telemetry, pregnancy-adapted imaging, echocardiography, cardiology, maternal-fetal medicine, and hematology.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Maternal hemodynamic instability: Hypotension, altered consciousness, ischemic chest pain, shock, severe ongoing tachyarrhythmia, or pulmonary edema requires immediate resuscitation and cause-specific cardiology, obstetric, and critical-care treatment.
• Pulmonary embolism warning: Sudden or progressive dyspnea, hypoxemia, pleuritic pain, syncope, hemoptysis, unexplained tachycardia, or unilateral leg swelling requires prompt pregnancy-adapted thromboembolism evaluation and treatment when indicated.
• Heart failure pattern: Orthopnea, paroxysmal nocturnal dyspnea, elevated neck veins, pulmonary crackles, new edema, gallop, or rapidly declining function raises concern for cardiomyopathy and needs urgent echocardiographic assessment.
• Severe systemic driver: Marked anemia with ischemic symptoms, thyroid storm features, infection, hemorrhage, or significant electrolyte disturbance can destabilize rhythm and circulation and requires direct treatment of the underlying disorder.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Physiologic pregnancy adaptation#

What supports it. Mild exertional awareness, gradual sinus tachycardia, brief benign ectopy, and otherwise normal examination, oxygenation, ECG, and functional capacity can reflect expected hemodynamic change.

What argues against it or keeps uncertainty open. Progressive limitation, orthopnea, syncope, irregular sustained rhythm, focal calf swelling, hypoxemia, or abnormal cardiac findings are not safely explained as normal pregnancy.

Discriminating next step. Document vital signs and ECG, compare function with baseline, and test the specific abnormal clues rather than using gestational age as the diagnosis.

Clinically important arrhythmia#

What supports it. Abrupt episodes, documented narrow or wide complex tachycardia, atrial fibrillation, frequent symptomatic ectopy, syncope, or known structural disease supports a rhythm disorder.

What argues against it or keeps uncertainty open. Sinus rhythm during typical symptoms and a monitor showing only sparse ectopy lower arrhythmic probability, though intermittent events require adequate capture.

Discriminating next step. Obtain a 12-lead ECG during symptoms when possible, choose telemetry or ambulatory monitoring by event frequency, and assess structural heart disease and reversible triggers.

Iron deficiency anemia#

What supports it. Low hemoglobin with microcytosis, low ferritin in context, fatigue, pica, dietary risk, or bleeding can cause tachycardia and breathlessness and amplify other cardiopulmonary disease.

What argues against it or keeps uncertainty open. Focal calf swelling, orthopnea, hypoxemia, or reduced ventricular function cannot be attributed to anemia alone, especially when the anemia is modest.

Discriminating next step. Confirm cause and severity with blood count, iron studies, bleeding and nutrition history, then replace iron through a route suited to urgency, gestation, tolerance, and access.

Pulmonary thromboembolism#

What supports it. Pregnancy-associated risk, unilateral leg findings, pleuritic symptoms, syncope, hypoxemia, or unexplained tachycardia raises pretest probability for DVT or pulmonary embolism.

What argues against it or keeps uncertainty open. A convincing alternative diagnosis and negative testing obtained through a validated pregnancy pathway lowers probability, but symptoms alone are not specific enough to exclude a clot.

Discriminating next step. Apply a current pregnancy-adapted pathway, obtain compression ultrasound when DVT symptoms are present, and use indicated chest imaging rather than leaving meaningful residual uncertainty untreated.

Peripartum cardiomyopathy#

What supports it. New heart-failure symptoms late in pregnancy or postpartum with reduced left-ventricular systolic function and no better cause supports peripartum cardiomyopathy.

What argues against it or keeps uncertainty open. A normal echocardiogram and a complete alternative explanation lower probability, although early disease and other pregnancy-related cardiac conditions may need follow-up.

Discriminating next step. Obtain urgent echocardiography, ECG, cardiac biomarkers in context, and cardio-obstetric review, then plan pregnancy-compatible heart-failure therapy and delivery or postpartum monitoring.

Thyroid related tachycardia#

What supports it. Heat intolerance, tremor, weight loss despite pregnancy, goiter, eye findings, persistent sinus tachycardia, or atrial arrhythmia with abnormal thyroid tests supports thyrotoxicosis.

What argues against it or keeps uncertainty open. No compatible symptoms and normal pregnancy-interpreted thyroid testing makes thyroid disease less likely as the main cause.

Discriminating next step. Measure thyroid-stimulating hormone and free thyroid hormone with pregnancy-specific interpretation, assess severity, and coordinate endocrine and obstetric therapy if abnormal.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Assess maternal and fetal stability. Blood pressure, oxygen saturation, respiratory effort, perfusion, mental status, chest findings, edema, obstetric symptoms, and fetal assessment determine the immediate level of care. Interpretation: Instability triggers resuscitation by physiology and urgent multidisciplinary care. A reassuring fetal check does not make maternal hypoxemia or shock safe.
• Capture rhythm and event burden. A 12-lead tracing, telemetry, or ambulatory monitor distinguishes sinus tachycardia, ectopy, supraventricular tachycardia, atrial fibrillation, and ventricular rhythm. Interpretation: Treatment depends on rhythm, duration, symptoms, and structural disease. An irregular pulse should not automatically be called anxiety or treated as an unstable arrhythmia without identification.
• Test reversible systemic causes. Blood count, iron studies, electrolytes, thyroid function, infection evaluation, and bleeding history identify common drivers that can produce or worsen palpitations. Interpretation: Correcting anemia or thyroid disease may improve symptoms but does not explain away focal thrombotic or heart-failure evidence.
• Apply pregnancy adapted clot testing. Pretest assessment, DVT examination, compression ultrasound, and appropriate chest imaging can evaluate embolism while minimizing delay and unnecessary exposure. Interpretation: A proven proximal DVT in a compatible presentation establishes treatment need. If respiratory severity is not explained, chest evaluation and hemodynamic assessment may still be necessary.
• Obtain echocardiographic assessment. Ventricular function, chamber size, valves, right-heart strain, pressure estimates, and pericardium identify cardiomyopathy and other structural causes without ionizing radiation. Interpretation: Reduced systolic function reframes ectopy as a possible consequence or marker of structural disease and requires cardio-obstetric management and serial follow-up.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

ECG captures frequent ventricular ectopy but not a sustained unstable rhythm. Echocardiography then shows reduced left-ventricular systolic function, moving peripartum cardiomyopathy to the front of the assessment. Compression ultrasound also confirms proximal deep-vein thrombosis, allowing anticoagulation to begin without waiting for chest imaging; worsening respiratory status would still require direct pulmonary embolism assessment and higher-acuity care.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Stabilize the identified threat. Treat shock, hypoxemia, pulmonary edema, sustained unstable rhythm, severe anemia, or thyroid crisis according to the actual physiology. Synchronized cardioversion or other emergency treatment should not be withheld solely because of pregnancy when indicated.
• Treat arrhythmia with pregnancy context. Choose vagal maneuvers, medication, cardioversion, anticoagulation, or electrophysiology input according to the documented rhythm, stability, gestation, structural disease, and current guidance rather than symptom label alone.
• Anticoagulate confirmed thrombosis. Use a pregnancy-appropriate anticoagulant and plan peripartum interruption, neuraxial considerations, bleeding surveillance, and postpartum duration with obstetric and hematology teams. Do not delay treatment for avoidable imaging sequencing.
• Manage cardiomyopathy jointly. Pregnancy-compatible heart-failure therapy, volume management, rhythm care, fetal surveillance, delivery planning, and postpartum reassessment require cardiology, maternal-fetal medicine, anesthesia, and critical-care coordination.
• Correct anemia and endocrine drivers. Replace iron and treat thyroid or other systemic disease according to severity and cause, while checking that cardiopulmonary symptoms respond as expected. Persistent discordance reopens the differential.
• Extend surveillance postpartum. Thrombotic and cardiomyopathy risks continue after birth. The discharge plan must cover medication compatibility, warning symptoms, contraception or future pregnancy counseling, imaging, and a reachable cardiology owner.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Compare the small, concrete risks of indicated imaging or medication with the consequences of a missed clot or failing heart, using absolute terms where data permit. Ask about pregnancy and feeding goals, include the patient in delivery and postpartum planning, and avoid language that frames maternal care as competing with the fetus.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Use emergency care for chest pain, fainting, severe or resting breathlessness, coughing blood, blue color, confusion, or a sustained rapid heartbeat with weakness.
• Report new one-sided leg swelling or pain immediately and follow the anticoagulant missed-dose, bleeding, and delivery plan exactly.
• Seek urgent review for orthopnea, rapidly increasing edema, reduced urine, sudden weight gain, or declining ability to perform ordinary activities.
• Keep postpartum cardiology and thrombosis appointments even if symptoms improve after delivery, with proactive outreach for a missed visit.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Symptoms are more likely to be dismissed when care is fragmented or affected by racism, language barriers, rural distance, disability, or lack of prenatal access. Provide interpreter-supported triage, transportation, blood-treatment access, medication coverage, blood-pressure equipment when useful, and postpartum cardiology follow-up that does not depend on broadband or unpaid caregiving.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Distinguishes expected pregnancy awareness from progressive functional loss, orthopnea, hypoxemia, and focal thrombotic findings.
• Captures an irregular rhythm before assigning a rhythm-specific treatment pathway.
• Uses compression ultrasound and indicated chest imaging without framing maternal diagnosis as a fetal harm.
• Recognizes reduced ventricular function as a major finding that can coexist with anemia, ectopy, or thrombosis.
• Builds antepartum, delivery, and postpartum follow-up into one cardio-obstetric plan.

Key takeaways#

• Progressive breathlessness, orthopnea, syncope, focal leg swelling, or an abnormal ECG should not be normalized as pregnancy alone.
• Hemodynamic instability requires cause-specific resuscitation rather than automatic treatment for an assumed arrhythmia.
• Cardiomyopathy and venous thrombosis can coexist, so one positive finding should not prematurely close the assessment.